TRANSNATIONALE.ORG
Subscribe ! Log in
Log out
SEARCH  web site
COMPANIES
Discover the reality of companies and brands !

UCB Group

Headquarters : Allée de la Recherche 60 1070 Brussels Belgium Belgium web www.ucb-group.com tel. 32-2-559-99-99 stock : UCB analytics

Brands

name
click to compare prices
Actias Réassurance SA
Celltech Group, Cimzia, Cogefina SA, Crylcoat
Doutors Reassurance SA
Fipar Ltd
Keppra
Lortab
Société Financière UCB SA, Surface Specialities Italy Srl
UCB, UNI Mediflex Private, Union Chimique Belge
Vedim
Zyrtec
» Shop local, ethical and at the best price on Ethishop
« ETHICAL » RATING OF UCB GROUP , group and subsidiaries
[click on the rating for the method or on the number for the data]
Jobs -2% /1998 Pollution 1 Fraud 1 Offshore 6 Sales 3 Bn $.€ /year Profit 2 Bn $.€ /1998 Influence 4 Infocom 1
subsidiarycountry%source
Genfit France Les Echos
Schwarz Pharma AG Germany100Bloomberg
» More subsidiaries of UCB Group
country
address & contact : production type
incentive source
South Africa South Africa
UCB Ltd. :
 Company
Brazil Brazil
UCB do Brasil Lda. :
 Company
China China
Shangai UCB Speciality Chemicals Co. Ltd. :
 Company
South Korea South Korea
SK UCB Co. Ltd. (50%) :
 Company
South Korea South Korea
Korea UCB Co. Ltd. :
 Company
Hong-Kong Hong-Kong
UCB Pharma Ltd. :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Hungary Hungary
UCB Hungary :
 Company
India India
UNI Mediflex Private Ltd. :
 Company
India India
UCB India Private Ltd. :
 Company
Ireland Ireland
UCB Ireland Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Luxembourg Luxembourg
Société Financière UCB SA :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Luxembourg Luxembourg
Actias Réassurance SA :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Malaysia Malaysia
UCB Asia Pacific Sdn Bhd :
 Company
Mexico Mexico
UCB de Mexico SA de CV :
 Company
Mexico Mexico
Vedim SA de CV :
 Company
Philippines Philippines
UCB Philippines Inc. :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Poland Poland
Vedim Sp. z o.o. :
 Company
Poland Poland
UCB Pharma Sp. z o.o. :
 Company
Czech Republic Czech Republic
UCB Pharma SRO :
 Company
Singapore Singapore
UCB Singapore Private Ltd. :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Switzerland Switzerland
UCB Investissements SA :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Switzerland Switzerland
Doutors Reassurance SA :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Switzerland Switzerland
Cogefina SA :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Switzerland Switzerland
UCB Pharma AG :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Switzerland Switzerland
UCB Farchim SA :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Company
Thailand Thailand
Fipar Ltd :
 Company
Thailand Thailand
Surface Specialities Ltd. (96,27%) :
 Company
Thailand Thailand
UCB Pharma Ltd. :
 Company
Turkey Turkey
UCB Pharma AS :
 Company
» More locations of UCB Group
» The World map of tax haven, secret accounts and shell companies

  • Human impact

year name
photo position; compensation
source
2004Janssen, André
See the photo of: Janssen, André Honorary Director;
Company
2003Belgium, H.R.H. Prince Lorenz of
See the photo of: Belgium, H.R.H. Prince Lorenz of Director;
Company
2003Blinken, Alain
See the photo of: Blinken, Alain Director;
Company
2003Boone, Baron Karel
See the photo of: Boone, Baron Karel Director;
Company
2003DIDISHEIM, Count
See the photo of: DIDISHEIM, Count Honorary Director;
Company
2003Janssen, Baron Daniel
See the photo of: Janssen, Baron Daniel Deputy Chairman;
Company
2003Jaumotte, Baron
See the photo of: Jaumotte, Baron Honorary Chairman of the Board of Directors;
Company
2003KEUTGEN, Guy
See the photo of: KEUTGEN, Guy Director;
Company
2003Roden, Baron de Neve de
See the photo of: Roden, Baron de Neve de Honorary Director;
Company
2003Van Rijckevorsel, Jean
See the photo of: Van Rijckevorsel, Jean Director;
Company
2003VELGE, Baron
See the photo of: VELGE, Baron Honorary Director;
Company
2000DIDISHEIM, Count
See the photo of: DIDISHEIM, Count Director;
Company
2000Du Monceau de Bergendal, Count Diego
See the photo of: Du Monceau de Bergendal, Count Diego Director;
Company
2000EYSKENS, Mark
See the photo of: EYSKENS, Mark Chairman of the Board;
Company
2000JACOBS, Baron
See the photo of: JACOBS, Baron Director;
Company
2000Janssen, Baron Daniel
See the photo of: Janssen, Baron Daniel Director;
Company
2000JANSSEN, Eric
See the photo of: JANSSEN, Eric Director;
Company
2000KEUTGEN, Guy
See the photo of: KEUTGEN, Guy Director;
Company
2000SAVERYS, Philippe
See the photo of: SAVERYS, Philippe Director;
Company
2000VANHERWEGHEM, Jean-Louis
See the photo of: VANHERWEGHEM, Jean-Louis Director;
Company
2000VELGE, Baron
See the photo of: VELGE, Baron Director;
Company
» More executive salaries for UCB Group
» Highest paid executives in 2007
year
employees
<>
social impact : country
source
2008
12000
-2000
Internal restructuring: UCB cuts 17% of its payroll, because of the competition of the generic drugs to the Zyrtec and the Keppra.:
Les Echos
2007
-219
Merger/Acquisition: UCB cuts 40% of its payroll in France because of its merger with Schwarz and the price falls of its drugs decided by the government.: France
Les Echos
2004
-80
Company
2003
11559
 Company
2002
10326
 Company
2000
9910
 Company
1999
8000
 Company
» More restructuring at UCB Group
» Layoff plans and labour conditions in 2007
year
employees
<>
social impact : country
source
 7 informations, access to subscribers
» More restructuring at UCB Group
» Layoff plans and labour conditions in 2007
year
country : consequences
source
2004France : Condamné par la justice française à verser 310.000 euros de dommages et intérêts à deux jeunes femmes atteintes d'un cancer causé par la prise de Distilbène (DES) par leur mère lors de sa grossesse. Décision confirmée par la Cour de cassation: "Devant ces risques connus et identifiés sur le plan scientifique, UCB Pharma n'avait pris aucune mesure, ce qu'elle aurait dû faire même en présence de résultats discordants quant aux avantages et inconvénients", a jugé la Cour.Les Echos
» More environmental impacts by UCB Group
» Pollutions in 2007
year
country : consequences
source
 1 informations, access to subscribers
» More environmental impacts by UCB Group
» Pollutions in 2007

  • Subsidy

yearfinancial misdemeanorsalesincome source
2004   3.070.36   billion Eu€Company
2004 Amende de 10 millions d'euros infligée par la Commission Européenne pour cartel de la vitamine B-4     Reuters
2003   2.960.34   billion Eu€Les Echos
2002   2.510.33   billion Eu€Company
2001   2.480.32   billion Eu€Company
2000   2.440.25   billion US$Company
» More financial data for UCB Group
» Financial delinquency in 2007
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 6 informations, access to subscribers
» More financial data for UCB Group
» Financial delinquency in 2007
year
purpose : intermediary/lobby : institution
source
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA
1999Market admission for genetically modified organisms : EuropaBio : : European Commission translateCorporate Europe Observatory
» More influence from UCB Group
» Influence in 2007
year
purpose : intermediary/lobby : institution
source
 2 informations, access to subscribers
» More influence from UCB Group
» Influence in 2007
year
dubious practice : image
source
2003Arguable partnership: Red Cross through the latter's annual campaign of self-adhesive stickers.: Company
» More ads and public relations campaign from UCB Group
» Dubious practices in 2007
Your contributions (0)
Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2009